Clinical Trials Directory

Trials / Completed

CompletedNCT02700126

Impact of Genetic Polymorphism on Propofol Requirement and Recovery for Total Intravenous Anesthesia for Clipping of Unruptured Cerebral Aneurysm in Korean Population

Status
Completed
Phase
Study type
Observational
Enrollment
118 (actual)
Sponsor
Yonsei University · Academic / Other
Sex
All
Age
19 Years
Healthy volunteers
Not accepted

Summary

In neurosurgical anesthesia, propofol based total intravenous anesthesia (TIVA) is frequently used due to brain relaxation and less effect on electrophysiologic monitoring. Response to propofol can vary between individuals and be associated with clinical factors including age and weight, and genetic polymorphism. Because the importance of rapid recovery in neurosurgery with long operation time is emphasized recently, the choice and dose adjustment of anesthetics should be determined according to clinical and genetic factors. Recently, researches about genetic variations have been performed with single nucleotide polymorphism (SNP). The aim of this study is to determine SNPs associated with propofol recovery and response in Korean adult population undergoing propofol based TIVA for clipping of unruptured cerebral aneurysm.

Conditions

Timeline

Start date
2016-03-07
Primary completion
2017-02-22
Completion
2017-02-22
First posted
2016-03-07
Last updated
2017-03-10

Locations

1 site across 1 country: South Korea

Source: ClinicalTrials.gov record NCT02700126. Inclusion in this directory is not an endorsement.